Kimberly-Clark Acquisition of Safeskin Completed
Safeskin Shareholders Approve Transaction
DALLAS, TX-The acquisition agreement signed in November 1999 between Kimberly-Clark Corporation and Safeskin Corporation has been approved by Safeskin shareholders. By approving the merger, Safeskin shareholders gave Kimberly-Clark entrance to the latex and synthetic glove market. Chairman and chief executive officer of Kimberly-Clark, Wayne R. Sanders, commented, "Safeskin has built one of the fastest growing, most technologically innovative and cost-effective businesses in the glove industry. We are pleased to complement our expanding offering of professional healthcare products with Safeskin gloves. With this acquisition, we will be able to offer a complete line of head-to-toe protection products for healthcare workers."
Valued at $800 million, the transaction includes issuing Safeskin shareholders .1956 of a share of Kimberly-Clark common stock for each share of Safeskin common stock. David R. Murray, president of Kimberly-Clark's professional healthcare sector will assume leadership of the Safeskin line and Richard Jaffe, chairman, president and chief executive officer of Safeskin will become a company consultant.
IDEA in Action: A Strategic Approach to Contamination Control
January 14th 2025Adopting IDEA—identify, define, explain, apply—streamlines contamination control. Infection control professionals can mitigate risks through prevention, intervention, and training, ensuring safer health care environments and reducing frequent contamination challenges.
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Long-Term Chronicles: Infection Surveillance Guidance in Long-Term Care Facilities
January 8th 2025Antibiotic stewardship in long-term care facilities relies on McGeer and Loeb criteria to guide infection surveillance and appropriate prescribing, ensuring better outcomes for residents and reducing resistance.
Considering Avian Flu: World Health Organization Expert Warns Against Raw Milk
January 6th 2025Drinking raw milk poses risks of disease transmission, especially with H5N1 outbreaks. Expert Richard J. Webby, PhD, advises against raw cow or goat milk consumption due to its unpredictable and significant risks.
